Microbiology & Infectious Diseases

Chronic exposure to cigarette smoke (CS) may significantly worsen the severity of influenza A virus (IAV) infections, not only through direct lung damage but also via changes in the microbiota.

Twice-yearly lenacapavir injections have shown remarkable efficacy in preventing HIV infection, offering a promising alternative to daily oral PrEP for males and gender-diverse individuals.

The response to tamoxifen, a cornerstone drug in preventing breast cancer recurrence, may hinge on an unexpected factor: gut bacteria.

Pandrug-resistant Klebsiella pneumoniae strains isolated from Ukrainian war victims are raising red flags for healthcare professionals worldwide.

A new study highlights partial resistance to artemisinin in Ugandan children with severe malaria, raising concerns about the efficacy of frontline treatments in sub-Saharan Africa.

In October 2023, a confirmed local dengue case in Pasadena, California marked a concerning milestone for the state’s public health officials.

A recent study reveals that COVID-19 booster shots significantly reduce the risk of developing venous thrombosis or embolism (VTE) following SARS-CoV-2 infection.

An agreement has been issued by the United States Centers for Disease Control and Prevention (CDC) to partner with Alveo Technologies to develop a rapid, point-of-need diagnostic test for detecting avian influenza A(H5) in humans.